Literature DB >> 18551751

Site and tumor type predicts DNA mismatch repair status in cutaneous sebaceous neoplasia.

Rajenda S Singh1, Wayne Grayson, Mark Redston, A Hafeez Diwan, Carla L Warneke, Phillip H McKee, Dina Lev, Stephen Lyle, Eduardo Calonje, Alexander J F Lazar.   

Abstract

Cutaneous sebaceous neoplasia is known to exhibit a high degree of DNA mismatch repair (MMR) deficiency leading to microsatellite instability and these tumors can be markers of the Muir-Torre syndrome and internal malignancy. Other tumors, such as colonic carcinoma, show tendencies toward particular histologic features and sites of involvement correlating with MMR deficiency. There are few comprehensive studies of unselected cutaneous sebaceous neoplasms. To address this gap in knowledge, we examined 94 sebaceous neoplasms from 92 patients and 17 sebaceous hyperplasia controls using immunohistochemistry for MLH1, MSH2, and MSH6. Our results indicate that MMR deficiency is significantly associated with anatomic location (more frequently in the trunk and extremities as compared with head and neck), tumor type (more often in adenoma compared with carcinoma within the head and neck region), and architecture (keratoacanthomalike). No correlation between cystic change and MMR deficiency was noted. Cutaneous sebaceous neoplasia has tendencies toward certain tumor types and anatomic distribution based on MMR status analogous to that seen in colonic carcinomas and other tumors. These may be helpful indicators for further workup for the Muir-Torre syndrome.

Entities:  

Mesh:

Year:  2008        PMID: 18551751     DOI: 10.1097/pas.0b013e31815b0cc2

Source DB:  PubMed          Journal:  Am J Surg Pathol        ISSN: 0147-5185            Impact factor:   6.394


  15 in total

Review 1.  Sebaceous neoplasia and the Muir-Torre syndrome: important connections with clinical implications.

Authors:  Sara C Shalin; Stephen Lyle; Eduardo Calonje; Alexander J F Lazar
Journal:  Histopathology       Date:  2010-01       Impact factor: 5.087

2.  p53 staining correlates with tumor type and location in sebaceous neoplasms.

Authors:  Sara C Shalin; Aniket Sakharpe; Stephen Lyle; Dina Lev; Eduardo Calonje; Alexander J Lazar
Journal:  Am J Dermatopathol       Date:  2012-04       Impact factor: 1.533

Review 3.  Validation of Immunohistochemical Assays for Integral Biomarkers in the NCI-MATCH EAY131 Clinical Trial.

Authors:  Joseph D Khoury; Wei-Lien Wang; Victor G Prieto; L Jeffrey Medeiros; Neda Kalhor; Meera Hameed; Russell Broaddus; Stanley R Hamilton
Journal:  Clin Cancer Res       Date:  2017-08-24       Impact factor: 12.531

Review 4.  The molecular genetics of eyelid tumors: recent advances and future directions.

Authors:  Tatyana Milman; Steven A McCormick
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2012-12-30       Impact factor: 3.117

5.  Changes in gene expression in human meibomian gland dysfunction.

Authors:  Shaohui Liu; Stephen M Richards; Kristine Lo; Mark Hatton; Aaron Fay; David A Sullivan
Journal:  Invest Ophthalmol Vis Sci       Date:  2011-04-25       Impact factor: 4.799

Review 6.  Genetic counseling considerations in the evaluation of families for Lynch syndrome--a review.

Authors:  Scott M Weissman; Cecelia Bellcross; Christina Chimera Bittner; Mary E Freivogel; Joy Larsen Haidle; Pardeep Kaurah; Anna Leininger; Selvi Palaniappan; Kelle Steenblock; Thuy M Vu; Molly S Daniels
Journal:  J Genet Couns       Date:  2010-10-08       Impact factor: 2.537

7.  Ileocecal adenocarcinoma and ureteral transitional cell carcinoma with multiple sebaceous tumors and keratoacanthomas in a case of muir-torre syndrome.

Authors:  Michael C Lynch; Bryan E Anderson
Journal:  Dermatol Res Pract       Date:  2010-08-15

8.  Screening for Muir-Torre syndrome using mismatch repair protein immunohistochemistry of sebaceous neoplasms.

Authors:  Maegan E Roberts; Douglas L Riegert-Johnson; Brittany C Thomas; Colleen S Thomas; Michael G Heckman; Murli Krishna; David J DiCaudo; Alina G Bridges; Katherine S Hunt; Kandelaria M Rumilla; Mark A Cappel
Journal:  J Genet Couns       Date:  2012-12-06       Impact factor: 2.537

9.  Sebaceoma of a Meibomian Gland of the Upper Eyelid.

Authors:  Frederick A Jakobiec; Paula Cortes Barrantes; Tatyana Milman; Michael Yoon
Journal:  Ocul Oncol Pathol       Date:  2020-01-22

Review 10.  [Differential diagnostics of sebaceous tumors].

Authors:  A Böer-Auer
Journal:  Pathologe       Date:  2014-09       Impact factor: 1.011

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.